Bradley W E, Dinelle C, Charron J, Langelier Y
Institut du Cancer de Montréal, Hôpital Notre-Dame, Canada.
Somatic Cell Genet. 1982 Mar;8(2):207-22. doi: 10.1007/BF01538678.
Four independent mutants were isolated from mutagenized cultures of CHO cells by sib selection on the basis of resistance to a low concentration (2.6 x 10(-5) M) of BrdU. All four lines were stable, but all had about 100% of the wild-type (WT) specific activity of thymidine kinase (TK). None of the four yielded derivatives resistant to a high level of BrdU (2 x 10(-4) M) in one step even after mutagenesis, but variants resistant to 4-6 x 10(-5) M BrdU could be isolated at frequencies of about 2 x 10(-5)/cell. At frequencies of 10(-4)-10(-5), the second-step mutants gave colonies resistant to 2 x 10(-4) M BrdU. The second and third steps of resistance were correlated with partial and complete reduction, respectively, in the specific activity of TK, suggesting that the variants may be genotypically heterozygous and homozygous-negative at the tk locus. The first step of BrdU resistance was dominant and appeared to result from a mutation in the gene from ribonucleotide reductase, since in vitro assays on partially purified preparations showed that the reductase activity in mutant cells was less sensitive to BrdUTP than in WT cells.
通过对中国仓鼠卵巢(CHO)细胞诱变培养物进行同胞选择,基于对低浓度(2.6×10⁻⁵ M)溴脱氧尿苷(BrdU)的抗性,分离出了四个独立的突变体。所有四条细胞系都很稳定,但它们的胸苷激酶(TK)的比活性都约为野生型(WT)的100%。即使经过诱变,这四个突变体中没有一个能一步产生对高浓度BrdU(2×10⁻⁴ M)有抗性的衍生物,但对4 - 6×10⁻⁵ M BrdU有抗性的变体可以以约2×10⁻⁵/细胞的频率分离出来。第二步突变体以10⁻⁴ - 10⁻⁵的频率产生了对2×10⁻⁴ M BrdU有抗性的菌落。抗性的第二步和第三步分别与TK比活性的部分降低和完全降低相关,这表明这些变体在tk基因座可能是基因型杂合和纯合阴性。第一步对BrdU的抗性是显性的,似乎是由核糖核苷酸还原酶基因的突变引起的,因为对部分纯化制剂的体外测定表明,突变细胞中的还原酶活性对BrdUTP的敏感性低于野生型细胞。